Tempest Adopts Limited Duration Stockholder Rights Plan
Unfortunately, Tempest, like many other biotechnology companies, continues to experience a significant and ongoing dislocation in the trading price of its common stock.
DarkPulse, Inc. Provides Letter to Shareholders from CEO subject to the approval of any banking partners associated with any up list, as part of any up list we may create a rights offering whereby existing shareholders would be eligible to purchase shares of the Company at discount.
Oct. 11, 2023 Tempest Adopts Limited Duration Stockholder Rights Plan
Unfortunately, Tempest, like many other biotechnology companies, continues to experience a significant and ongoing dislocation in the trading price of its common stock.
RNVA debt restructuring news that would not have happened unless Q3 earnings kicked ass (10-Q due 11/15). Investors simply need to buy out the remaining shares of one bad actor being forced out under SEC insider trading rules at a major discount to buyers. Buy out the shares left in the Sabby prospectus, and the stock price values in well above the 000s, and fast, no insider sellers in the way. Sabby is selling .0001s. Go RNVA.